Diabetes the most costly health condition in the U.S. Health Canada approves app-enabled Contour Next One blood glucose monitoring systemProvides blood glucose reading accuracy to within 8.4% of lab readings. Alberta pharmacists’ diabetes management activities increase over past nine years Study examines factors affecting the number of diabetes management activities provided by pharmacists. Chlorpropamide to be discontinued in Canada before mid-2017 Patients taking chlorpropamide must be switched to an alternate therapy for type 2 diabetes. Canadian Diabetes Association recognizes cardiovascular benefits of liraglutide Revised interim statement includes liraglutide as an option for adults with type 2 diabetes and clinical cardiovascular disease. Artificial intelligence screens for diabetic retinopathy Google scientists say ‘deep learning’ algorithm has high sensitivity and specificity Some SGLT2 inhibitors increase risk of loss of bone mineral density and fracture Rare side effect reported with canagliflozin, and with dapagliflozin in patients with moderate renal impairment. $1 million commitment to improve wellness around the globe through diabetes prevention and management A cost-cutting success story: Limiting test-strip reimbursement does not harm diabetes patients Ontario decision saved millions without worsening rates of dysglycemia, study finds Diabetes international press review – October 26, 2016 First Previous 25 26 27 28 29 Next Last
